IDEAYA Biosciences, Inc.
IDYA· Nasdaq
Filed Nov 13, 2019 · 10-Q · 44 days after period end · 0001564590-19-043225
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Net Income | -$10.97M | -$13.05M |
| EPS Diluted | -$0.54 | -$13.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end